Medical Resources has closed the book on Chapter 11—and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the
Medical Resources has closed the book on Chapter 11-and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the remaining equity distributed to other creditors and plaintiffs in lawsuits. PreChapter 11 shareholders will receive no distributions, and their shares of common stock will be canceled. With fewer than 300 record holders of its common stock, the company is no longer subject to the reporting requirements of the Securities Exchange Act of 1934. Medical Resources, which owns 70 imaging centers, marked completion of the restructuring by acquiring new MRI and CT scanners for its Springfield (PA) Diagnostic Imaging Center and Sarasota (FL) Outpatient affiliates.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.